Results 191 to 200 of about 72,117 (254)

From N-of-1 to versatility in propionic acidemia: Antisense oligonucleotide-mediated skipping of a constitutive <i>PCCA</i> pseudoexon. [PDF]

Mol Ther Nucleic Acids
Totsune E, Wada Y, Mikami-Saito Y, Arai-Ichinoi N, Saijo N, Takayama J, Maeda Y, Nakajima Y, Ohara O, Kure S, Kikuchi A.   +10 more
europepmc   +1 more source

Antisense Oligonucleotides: Technological Advances, Clinical Progress, and Expanding Therapeutic Frontiers. [PDF]

Pharmaceutics
Xu L, Zhang H, Jiang B, Jiang Y, Lu H.
europepmc   +1 more source

Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemia. [PDF]

Front Oncol
Lin HY, Khou S, Lind E, de Oliveira Rebola KG, Dean A, Zhang H, Tolentino A, Maazi H, Revenko A, Agarwal A.   +9 more
europepmc   +1 more source

RNA-based precision medicine in glioblastoma driven by oncogenic gene fusions. [PDF]

Mol Ther Oncol
Bouillon M, Lapoujade C, Basset L, Fontaine A, Hollenstein M, Garcion E, Rousseau A.   +6 more
europepmc   +1 more source

Bridge Nucleic Acid/DNA Gapmers as Potential Inhibitors of Bacterial Gene Expression by Multiple Antisense Mechanisms: An In Vitro Study. [PDF]

Molecules
Magaña AJ, Phan K, Lopez JA, Ramirez MS, Tolmasky ME.   +4 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source